Chennai-headquartered Orchid Pharma has posted its Q4 FY13 results. The company has reported a revenue of Rs 268.16 crores in Q4 FY13 versus Rs 490.78 crores in Q4 FY12. Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is of Rs 13.98 crores in Q4 FY13 versus Rs 89.5 crores in Q4 FY12.
Loss before tax of Rs 116.82 crores is reported in Q4 FY13 compared to a loss before tax of Rs 11.98 crores during Q4 FY12. At the net level, the company registered a loss (after exceptional item loss of Rs 6.40 crores) of Rs 132.27 crores in Q4 FY13 compared to a profit of Rs 20.55 crores during Q4 FY12.
The financial highlights for 12-months ended March 31, 2013 are as follows. Revenue of Rs 1269.46 crores in the 12-months ended March 31, 2013 versus Rs 1764.64 crores in the corresponding period of last fiscal. EBITDA of Rs 132.58 crores in the 12-months ended March 31, 2013 versus Rs 411.71 crores in the same period of last fiscal. Loss before tax (before exceptional item gain of Rs 26.15 crores) of Rs 302.67 crores in the 12-months ended March 31, 2013 compared to a loss before tax of Rs 0.26 crore during the corresponding period of last fiscal. Net loss after Tax (after exceptional item loss of Rs 26.15 crores) of Rs 275.37 crores in the 12-months ended March 31, 2013 compared to a net profit of Rs 103.11 crores registered during the same period last fiscal.
EP News Bureau – Mumbai
